Antiestrogenic effect of trifluoperazine in mice
- 15 June 1985
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 34 (12), 2221-2224
- https://doi.org/10.1016/0006-2952(85)90425-3
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984
- Changes in calmodulin and its mrna accompany reentry of quiescent (G0) cells into the cell cycleCell, 1984
- Inhibition of human breast cancer colony formation by anticalmodulin agents: Trifluoperazine, W-7, and W-13Cancer Chemotherapy and Pharmacology, 1983
- Antiestrogen-Binding Sites Distinct from the Estrogen Receptor: Subcellular Localization, Ligand Specificity, and Distribution in Tissues of the Rat*Endocrinology, 1983
- High-affinity anti-oestrogen binding site distinct from the oestrogen receptorNature, 1980
- A MONOHYDROXYLATED METABOLITE OF TAMOXIFEN WITH POTENT ANTIOESTROGENIC ACTIVITYJournal of Endocrinology, 1977
- Tamoxifen is a potent ‘pure’ anti-oestrogen in chick oviductNature, 1977
- TAMOXIFEN AS AN ANTI-TUMOUR AGENT: EFFECT ON OESTROGEN BINDINGJournal of Endocrinology, 1976
- Competition of Phenothiazines with Oestradiol for Oestradiol Receptors in Rat BrainNeuroendocrinology, 1971
- A NEW DERIVATIVE OF TRIPHENYLETHYLENE: EFFECT ON IMPLANTATION AND MODE OF ACTION IN RATSReproduction, 1967